lobbying_activities: 2180666

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2180666	ea300b8b-3082-4a74-8907-9b730ec334f0	Q3	BROYDRICK & ASSOCIATES	7268	EXELA PHARMA SCIENCES	2018	third_quarter	PHA	Drug shortages and FDA approval, USTR acceptance.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2018-10-05T18:23:11.293000-04:00